3 results
Approved WMORecruiting
To determine whether imaging-based techniques are a cost-effective and safe alternative to invasive pressure measurements when deciding on the indication for revascularization in stable CAD.
Approved WMOPending
In this study, we look at how safe the new medicinal product XMT-1536 is for the treatment of ovarian cancer and how well it works. We compare the effect of XMT-1536 with the effect of a placebo. A placebo is a product without the active ingredient…
Approved WMOPending
Primary Objective: This study will evaluate the efficacy, safety, and pharmacokinetics of RO7247669 plus nab-paclitaxel compared with pembrolizumab plus nab-paclitaxel in patients with previously untreated, locally advanced, unresectable or…